• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Figure 11. HBV DNA loss at followup off the drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model).

Figure 11HBV DNA loss at followup off the drug therapies for chronic hepatitis B (significant risk differences from individual RCTs and pooled with random effects model)

From: Appendix E Tables and Figures

Cover of Management of Chronic Hepatitis B
Management of Chronic Hepatitis B.
Evidence Reports/Technology Assessments, No. 174.
Wilt TJ, Shamliyan T, Shaukat A, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.